Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Open in API
Filings indexed 2,283 across all filing types
Latest filing 2026-05-18 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
辽宁成大股份有限公司关于与专业投资机构共同投资的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a listed company regarding the progress of a co-investment with professional investment institutions into a private fund. It outlines the amounts committed and paid, registration status, and future risk considerations. It is not a full annual/interim report, audit, dividend notice, proxy statement, or management discussion, but rather a disclosure of a financing/investment activity. Therefore it best fits the Capital/Financing Update category (CAP).
2026-05-18 Chinese
辽宁成大股份有限公司关于召开2025年年度暨2026年第一季度业绩暨现金分红说明会的公告
Regulatory Filings Classification · 75% confidence The document is an announcement of a 2025 annual and 2026 Q1 results and cash dividend explanation meeting (an investor briefing), including logistics (time, place, participation instructions). It does not contain actual financial data or the presentation slides themselves, nor is it a transcript. It is a general regulatory announcement that does not fit other specific categories, so it falls under the fallback Regulatory Filings category (RNS).
2026-05-14 Chinese
辽宁成大股份有限公司关于收到《关于辽宁成大股份有限公司非公开发行可交换公司债券符合深交所挂牌条件的无异议函》的公告
Regulatory Filings
2026-05-06 Chinese
辽宁成大股份有限公司独立董事2025年度述职报告（刘继虎）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2025 Annual Work Report" for Liaoning Chengda Co., Ltd. It details the independent director's activities, attendance at board and shareholder meetings, committee participation, exercise of duties, communication with auditors, and overall evaluation for the year 2025. The content focuses on the director's report on their responsibilities and oversight rather than financial statements or audit results. It is a narrative report on board/management information, specifically about the independent director's role and activities. The document length is 4278 characters, which is relatively short but contains substantive content about board/management activities rather than just an announcement or certification. Therefore, it fits best under Board/Management Information (MANG).
2026-04-24 Chinese
辽宁成大股份有限公司2025年度内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Audit Report" for the fiscal year ending December 31, 2025, issued by a registered accounting firm (Grant Thornton) to the shareholders of Liaoning Chengda Co., Ltd. It discusses the audit of the effectiveness of internal controls over financial reporting, referencing relevant Chinese auditing standards and internal control guidelines. The document contains an auditor's opinion on the effectiveness of internal controls but does not include full financial statements or comprehensive annual report content. It is a standalone audit report focused on internal control effectiveness rather than a full annual report or interim financial report. The document length is short (1222 characters), but it contains substantive audit opinion content, not merely an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR).
2026-04-24 Chinese
辽宁成大股份有限公司关于2025年度利润分配方案的公告
Notice of Dividend Amount Classification · 95% confidence The document is a formal announcement from a company regarding its 2025 annual profit distribution plan, including details on cash dividends per share, total dividend amount, and related financial figures. It includes references to audited net profits, dividend payout ratios, and the decision-making process by the board and audit committee. The document does not contain full financial statements or comprehensive financial performance data but focuses on the dividend distribution plan and related shareholder information. The document length is relatively short (2263 characters) and is clearly an announcement of a profit distribution scheme rather than a full annual report or interim report. Therefore, it fits best into the category of Notice of Dividend Amount (DIV).
2026-04-24 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.